BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20525687)

  • 1. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.
    Costa TR; Edqvist PJ; Bröms JE; Ahlund MK; Forsberg A; Francis MS
    J Biol Chem; 2010 Aug; 285(33):25269-84. PubMed ID: 20525687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant with aberrant extracellular LcrV-YscF interactions fails to form pores and translocate Yop effector proteins but retains the ability to trigger Yop secretion in response to host cell contact.
    Harmon DE; Murphy JL; Davis AJ; Mecsas J
    J Bacteriol; 2013 May; 195(10):2244-54. PubMed ID: 23475976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
    Francis MS; Lloyd SA; Wolf-Watz H
    Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of the YopD-lcrH interaction from Yersinia pseudotuberculosis reveals a role for hydrophobic residues within the amphipathic domain of YopD.
    Francis MS; Aili M; Wiklund ML; Wolf-Watz H
    Mol Microbiol; 2000 Oct; 38(1):85-102. PubMed ID: 11029692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
    Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
    Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN.
    Marenne MN; Journet L; Mota LJ; Cornelis GR
    Microb Pathog; 2003 Dec; 35(6):243-58. PubMed ID: 14580388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Yersinia Yop virulon: LcrV is required for extrusion of the translocators YopB and YopD.
    Sarker MR; Neyt C; Stainier I; Cornelis GR
    J Bacteriol; 1998 Mar; 180(5):1207-14. PubMed ID: 9495760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished LcrV secretion attenuates Yersinia pseudotuberculosis virulence.
    Bröms JE; Francis MS; Forsberg A
    J Bacteriol; 2007 Dec; 189(23):8417-29. PubMed ID: 17873031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.
    Amer AA; Åhlund MK; Bröms JE; Forsberg Å; Francis MS
    J Bacteriol; 2011 Dec; 193(23):6683-700. PubMed ID: 21965570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains.
    Olsson J; Edqvist PJ; Bröms JE; Forsberg A; Wolf-Watz H; Francis MS
    J Bacteriol; 2004 Jul; 186(13):4110-23. PubMed ID: 15205412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random mutagenesis identifies a C-terminal region of YopD important for Yersinia type III secretion function.
    Solomon R; Zhang W; McCrann G; Bliska JB; Viboud GI
    PLoS One; 2015; 10(3):e0120471. PubMed ID: 25807250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Amino-Terminal Part of the Needle-Tip Translocator LcrV of
    Ekestubbe S; Bröms JE; Edgren T; Fällman M; Francis MS; Forsberg Å
    Front Cell Infect Microbiol; 2016; 6():175. PubMed ID: 27995096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LcrQ Coordinates with the YopD-LcrH Complex To Repress
    Fei K; Yan H; Zeng X; Huang S; Tang W; Francis MS; Chen S; Hu Y
    mBio; 2021 Jun; 12(3):e0145721. PubMed ID: 34154409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissection of homologous translocon operons reveals a distinct role for YopD in type III secretion by Yersinia pseudotuberculosis.
    Bröms JE; Forslund AL; Forsberg Å; Francis MS
    Microbiology (Reading); 2003 Sep; 149(Pt 9):2615-2626. PubMed ID: 12949185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LcrV mutants that abolish Yersinia type III injectisome function.
    Ligtenberg KG; Miller NC; Mitchell A; Plano GV; Schneewind O
    J Bacteriol; 2013 Feb; 195(4):777-87. PubMed ID: 23222719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis.
    Hamad MA; Nilles ML
    J Bacteriol; 2007 Sep; 189(18):6734-9. PubMed ID: 17644582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.